FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

FFI FUND LTD		 2. Date of Event Requiring Statement (MM/DD/YYYY)
9/9/2021 

 3. Issuer Name and Ticker or Trading Symbol

Clarus Therapeutics Holdings, Inc. [CRXT]
(Last)        (First)        (Middle)

C/O BRACEBRIDGE CAPITAL, LLC, 888 BOYLSTON STREET, 15TH FLOOR		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

BOSTON, MA 02199      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 2229855 I See footnotes (1)(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1) 2,229,855 of the total reported shares of common stock, $0.0001 par value per share ("Common Stock"), of the Issuer are owned directly as follows: (i) 1,627,795 shares of Common Stock are owned directly by FFI Fund Ltd. ("FFI"), (ii) 312,179 shares of Common Stock are owned directly by FYI Ltd. ("FYI"), and (iii) 289,881 shares of Common Stock are owned directly by Olifant Fund, Ltd. (together with FFI and FYI, the "Bracebridge Funds"). Bracebridge Capital, LLC (the "Investment Manager") is the investment manager of each of the Bracebridge Funds, and has the authority to vote and dispose of all the shares of Common Stock reflected herein.
(2) Each of the Bracebridge Funds and the Investment Manager disclaims beneficial ownership of the shares of Common Stock except to the extent of any pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the shares of Common Stock reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
FFI FUND LTD
C/O BRACEBRIDGE CAPITAL, LLC
888 BOYLSTON STREET, 15TH FLOOR
BOSTON, MA 02199
X

FYI Ltd
C/O BRACEBRIDGE CAPITAL, LLC
888 BOYLSTON STREET, 15TH FLOOR
BOSTON, MA 02199
X

Olifant Fund, Ltd.
C/O BRACEBRIDGE CAPITAL, LLC
888 BOYLSTON STREET, 15TH FLOOR
BOSTON, MA 02199
X

Bracebridge Capital, LLC
888 BOYLSTON STREET, 15TH FLOOR
BOSTON, MA 02199
X
Signatures
/s/ FFI Fund Ltd., By Gabriel Sunshine, Authorized Representative9/17/2021
**Signature of Reporting PersonDate

/s/ FYI Ltd., By Gabriel Sunshine, Authorized Representative9/17/2021
**Signature of Reporting PersonDate

/s/ Olifant Fund, Ltd., By Gabriel Sunshine, Authorized Representative9/17/2021
**Signature of Reporting PersonDate

/s/ Bracebridge Capital, LLC, By Gabriel Sunshine, Authorized Representative9/17/2021
**Signature of Reporting PersonDate
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Clarus Therapeutics Charts.
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Clarus Therapeutics Charts.